By: Express Web Desk | New Delhi |Updated: July 8, 2020, 12:49:45 pm
Coronavirus India News Live Updates: Prime Minister Narendra Modi on Wednesday wished Brazilian President Jair Bolsonaro a speedy recovery from Covid-19. “My friend President @jairbolsonaro, my prayers and best wishes for your speedy recovery,” he tweeted.
Meanwhile, Delhi Chief Minister Arvind Kejriwal has sought a detailed analytical report from the Delhi government’s health secretary on factors responsible for COVID-19 deaths in the city in the last fortnight, according to PTI.
India has reported 482 deaths and 23,135 Covid-19 cases in the last 24 hours, pushing the total number of casualties to 20,653 and a total number of infections to 744,006 which includes 266,295 active cases, and 457,058 people who have been treated and discharged so far, according to the Ministry of Health and Family Welfare. The number of recovered cases exceeded that of the active cases by 1,91,886 on Tuesday.
On Tuesday, the Health Ministry assured that the country’s tally per million population is one of the lowest in the world. Referring to the WHO Situation Report-168′ dated July 6, the ministry said India’s COVID-19 cases per million population is 505.37 as against the global average of 1,453.25.
However, four months into the pandemic, Indian medical manufacturers catering to the swelling COVID industry are facing a unique dilemma over the use of a life-saving device at the heart of every ICU: ventilators. On the other hand, while 12 hospitals chosen to conduct clinical trials of Bharat Biotech’s Covaxin prepare to enroll participants this month, samples of the vaccine are still undergoing quality and safety tests at a government facility, The Indian Express has learned.
Globally, the total number of coronavirus cases has reached 11,798,678 while deaths stand at 543,535, according to Johns Hopkins University.
Covaxin trials: Vaccine checks underway, hospitals await nod
While 12 hospitals chosen to conduct clinical trials of Bharat Biotech’s Covaxin prepare to enroll participants this month, samples of the vaccine are still undergoing quality and safety tests at a government facility.
The tests, which began last Friday, are expected to be completed by the end of next week and cannot be rushed as they are expected to ensure the vaccines are safe to use in humans, said, senior officials.
Meanwhile, at least three of the hospitals – AIIMS in Delhi, SRM Hospital, and Research Centre in Kancheepuram and King George Hospital in Vishakhapatnam — are learned to still be awaiting ethics committee approvals to begin enrolling participants for the study. Other hospitals are awaiting site initiation visits and clearances to ensure their facilities are ready to conduct these trials.